Eli Lilly on Monday lowered the cost of Zepbound after the pharmaceutical giant and Ozempic maker Novo Nordisk announced a deal with the Trump administration to slash the prices of the popular weight-loss drugs. Read the full story on Forbes: https://www.forbes.com/sites/tylerroush/2025/12/01/eli-lilly-lowers-weight-loss-drug-zepbound-prices-after-trump-deal/ Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1 Fuel your success with Forbes. Gain unlimited access to